Thursday, September 07, 2017 10:22:08 PM
IMO
They are re-negotiating Ibliss because it was not a done deal and far from it contrary to the numerous PR's that stated it was a final deal. $15M in revenue that will just fade away to nothing IMO. They will never acquire this company IMO, just like the others they announced and never panned out. IT was not reported on last Q even though it was reported as closed long before. So i guess Ibliss has zero sales or it was bullshyt.
They have not "diluted" recently but the 200M shares they gave for medicated markets that never closed are now gone apparently too my inexperienced knowledge. Is that not dilution?
The money they gave Amfil and the fact that they no longer hold any stock in that company, why is that not just said out right? What did they sell it for? What did they do with the funds?
What are they really doing?
All these massive name drops to tie association to, all it takes is an email to ask if there is a relationship to see if there is one or not. Anyone done it?
Nah. EAPH to the moon right.
Good god.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM